San Antonio, TX-based Mission Pharmacal Company, has acquired the U.S. prescription prenatal vitamins NataFort and NataChew, along with related U.S. patents, from subsidiaries of Warner Chilcott plc.

“Mission continues to expand its CitraNatal family of prenatal vitamins with the acquisition of the trusted NataFort and NataChew prenatal vitamins and the related U.S. patents,” said Neill Walsdorf, Jr., president of Mission Pharmacal Company. “NataFort and NataChew are positive additions to the many types of nutritional support provided to women by CitraNatal prenatal vitamins before, during and after pregnancy.”

NataFort is a prenatal multivitamin tablet with two types of iron. It improves the nutritional status of women prior to conception and provides vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non-lactating mother.

NataChew is a chewable prenatal multivitamin tablet with iron. It improves the nutritional status of women prior to conception and provides vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non-lactating mother.

CitraNatal vitamins—marketed by Mission Pharmacal Company—are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy and during the postnatal period. The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation, Columbia, MD, under the trademark LifesDHA.